Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|Xenetic Biosciences, Inc. Reports Third ...||11/15/19|
|- Company ramps up activities to execute XCART's preclinical and regulatory strategy - - Cash runway expected to fund Company through preclinical adva...|
|Xenetic Biosciences, Inc. to Present at ...||10/29/19|
|FRAMINGHAM, MA / ACCESSWIRE / October 29, 2019 / Xenetic Biosciences, Inc. (XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on...|
|Date||04/12/2019 (AMC)||Est. (EPS/Rev.)||$1.37|
|Actual (EPS/Rev.)||$2.5B||EPS (TTM)||$???|